Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • The Discussion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • The Discussion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Health

Moderna’s mRNA-1273 is about 94 percent effective against COVID-19

Staff Writer
Staff Writer 2 years ago
Updated 2021/05/12 at 6:20 PM
Share
SHARE

The New England Journal of Medicine has publicized new clinical trial data of Moderna’s mRNA-1273 vaccine, reporting a high efficacy rate against COVID-19.

According to the data, which involved more than 30,000 participants, the vaccine demonstrated an efficacy rate of 94.1 percent against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain, in comparison to a placebo.

The clinical trial was conducted across countless sites within the United States, enrolling only adult participants with no prior infection of the viral disease. The vaccine was administered between late-July and late-October 2020.

An estimated 79 percent of the participants, or the majority, were white Americans, while 20 percent were Latino, and 10 percent were Black Americans.

Adverse reactions after receiving the vaccine were relatively mild, with only common symptoms such as headaches, muscle aches, and fatigue, present after the first and second dose.

All in all, Moderna’s mRNA-1273 vaccine, which received approval by the Food and Drug Administration, is a viable option to other available alternatives for combatting the virus.

The findings were published on December 30th, 2020.

Photo: BioSpace

You Might Also Like

Only less than 7 percent of U.S. adults have good cardiometabolic health

Study shows the likely outcomes of very preterm born children

Researchers find that stress accelerates immune aging

Study finds heavy drinkers are significantly more likely to smoke

Researchers suggest menthol cigarettes may raise the possibility of youth smoking and addiction

TAGGED: COVID-19, Moderna, mRNA-1273
Staff Writer January 1, 2021
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article Children of a sexual or gender minority are at a higher risk of obesity
Next Article Many people believe they are well informed on the COVID-19 pandemic

Recommended

Health

Only less than 7 percent of U.S. adults have good cardiometabolic health

1 Min Read
Health

Study shows the likely outcomes of very preterm born children

1 Min Read
Health

Researchers find that stress accelerates immune aging

2 Min Read
Health

Study finds heavy drinkers are significantly more likely to smoke

1 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?